enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Acquired generalized lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Acquired_generalized...

    The clinical presentation is similar to people with congenital lipodystrophy: the only difference is that AGL patients are born with normal fat distribution and symptoms develop in childhood and adolescence years and rarely begins after 30 years of age. [6] [7] Females are more often affected than males, with ratio being 3:1. [5] [6] [8] [page ...

  3. Lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Lipodystrophy

    The medicine is used in: adults and children above the age of two years with generalised lipodystrophy (Berardinelli-Seip syndrome and Lawrence syndrome) and in adults and children above the age of 12 years with partial lipodystrophy (including Barraquer-Simons syndrome), when standard treatments have failed.

  4. Barraquer–Simons syndrome - Wikipedia

    en.wikipedia.org/wiki/Barraquer–Simons_syndrome

    The disease may gradually progress. About 40-50% of patients develop end-stage renal disease over the course of 10 years. This condition is responsible for most recurrent hospital admissions in patients with acquired partial lipodystrophy. Rapid progression of renal disease in a pregnant patient was reported.

  5. Dunnigan familial partial lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Dunnigan_familial_partial...

    Familial Partial Lipodystrophy, Dunnigan Type Autosomal dominant is the manner of inheritance of this condition Dunnigan-type familial partial lipodystrophy , also known as FPLD Type II and abbreviated as ( FPLD2 ), is a rare monogenic form of insulin resistance characterized by loss of subcutaneous fat from the extremities , trunk , and ...

  6. Familial partial lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Familial_partial_lipodystrophy

    Familial partial lipodystrophy, also known as Köbberling–Dunnigan syndrome, [2] is a rare genetic metabolic condition characterized by the loss of subcutaneous fat. [ 3 ] : 495 FPL also refers to a rare metabolic condition in which there is a loss of subcutaneous fat in the arms, legs and lower torso.

  7. Moon face - Wikipedia

    en.wikipedia.org/wiki/Moon_face

    Moon face is among the most frequently reported adverse events of systemic glucocorticoids, along with insomnia (58%), mood disturbances (50%), and hyperphagia (49%). [ 8 ] Another long-term study of 88 patients on prednisone showed that lipodystrophy, such as moon face, was the most frequent adverse event, experienced by 63% of patients.

  8. Centrifugal lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/Centrifugal_lipodystrophy

    Centrifugal lipodystrophy is a skin condition characterized by areas of subcutaneous fat loss that slowly enlarge. [2]: 496–7 ...

  9. HIV-associated lipodystrophy - Wikipedia

    en.wikipedia.org/wiki/HIV-associated_lipodystrophy

    HIV-associated lipodystrophy commonly presents with fat loss in face, buttocks, arms and legs. [citation needed] There is also fat accumulation in various body parts. Patients often present with "buffalo hump"-like fat deposits in their upper backs. Breast size of patients (both male and female) tends to increase.